Grifols SA
(NASDAQ : GRFS)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.63%36.710.9%$1161.28m
JNJJohnson & Johnson 1.42%164.030.7%$1133.06m
LLYEli Lilly & Co. 1.87%206.141.1%$885.80m
ABBVAbbVie, Inc. 0.19%111.471.9%$727.30m
BMYBristol-Myers Squibb Co. 1.01%64.831.0%$672.03m
MRKMerck & Co., Inc. -0.07%81.130.7%$665.33m
AZNAstraZeneca Plc 1.43%53.301.2%$664.60m
ARCTArcturus Therapeutics Holdings, Inc. 6.37%67.840.0%$232.15m
GRTSGritstone Oncology, Inc. 2.37%26.160.0%$196.70m
VTRSViatris, Inc. 0.90%17.470.0%$194.53m
RPRXRoyalty Pharma Plc 1.75%51.300.2%$174.43m
NVSNovartis AG 0.11%96.990.2%$166.05m
GSKGlaxoSmithKline Plc 1.87%38.490.2%$149.44m
SNYSanofi 0.61%49.950.2%$129.25m
RGENRepligen Corp. 0.76%218.566.9%$82.30m

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.